RxVantage’s mission is to ensure every interaction between healthcare providers and life sciences results in a timely and relevant transfer of knowledge. To optimize patient care, it is essential that these educational interactions occur soon after a therapy receives FDA approval, a new indication, new warning or side effects, or other significant changes.
Fueled by insightful feedback from our user community, we’ve developed RxVantage Beacon, a set of intelligent new capabilities within RxVantage to ensure more timely educational interactions around important product news.
How it works
With RxVantage Beacon, practices can now easily configure their RxVantage accounts to prioritize the type of news that is most important to their doctors, staff, and ultimately patients.
-
Select the product news to prioritize – be it new product approvals, indications, label changes, clinical data updates or reimbursement changes.
-
Define how you like to learn and who needs to know – via in-person, virtual meetings or phone – and who on the care team will likely want to attend.
-
Apply these preferences to specific appointments on RxVantage, ensuring they are reserved for new product information.
RxVantage Beacon greatly improves the ability for RxVantage’s embedded intelligence to honor practice preferences and optimize the educational value of interactions between practices and life sciences. As always, all Life Sciences experts that meet practice criteria and preferences will be eligible to book these appointments, regardless of their account type.
We invite you to start using RxVantage Beacon today and share your feedback with us so we can continue to improve.
Practices can configure and activate RxVantage Beacon in their account by contacting their Account Manager or emailing support@rxvantage.com.
Life Sciences companies can contact your client team or email enterprise@rxvantage.com to share information about upcoming launches and to learn more about RxVantage Beacon.